Athenex, Inc. Profile Avatar - Palmy Investing

Athenex, Inc.

Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial …

Drug Manufacturers - Specialty & Generic
US, Buffalo [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Athenex, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Athenex, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Athenex, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of ATNX's Analysis
CIK: 1300699 CUSIP: 04685N103 ISIN: US04685N1037 LEI: - UEI: -
Secondary Listings
ATNX has no secondary listings inside our databases.